In this study, the anticancer activity of chamaejasmine was characterized in the human breast cancer cell line, MDA-MB-231. Cell viability and cell cycle distribution were determined by MTT assay and flow cytometry, respectively. Western blotting was performed to determine changes in levels of various proteins. Results showed that treatment with chamaejasmine (4-16 μM) inhibited cell proliferation, which correlated with G2/M phase arrest and apoptosis in MDA-MB-231 cells. Chamaejasmine treatment of MDA-MB-231 cells resulted in induction of WAF1/p21 and KIP1/p27, decrease in cyclins A and cyclins B1. Cyclin-dependent kinase (cdk) 2 and cdc2 was also decreased after chamaejasmine treatment. Moreover, inhibition of nuclear translocation, phosphorylation of NF-kB, activation of IKKa and IKKβ, inhibition of phosphorylation and degradation of IkBa were also detected in this work. Our findings suggested that chamaejasmine could be explored as a preventive and perhaps as a chemotherapeutic agent in the management of breast cancer. © 2013 by the authors.
CITATION STYLE
Zhang, T., Yu, H., Dong, G., Cai, L., & Bai, Y. (2013). Chamaejasmine arrests cell cycle, induces apoptosis and inhibits nuclear NF-kB translocation in the human breast cancer cell line MDA-MB-231. Molecules, 18(1), 845–858. https://doi.org/10.3390/molecules18010845
Mendeley helps you to discover research relevant for your work.